We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
NCI Announces Funding Opportunity for Biospecimen Core
News

NCI Announces Funding Opportunity for Biospecimen Core

NCI Announces Funding Opportunity for Biospecimen Core
News

NCI Announces Funding Opportunity for Biospecimen Core

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "NCI Announces Funding Opportunity for Biospecimen Core"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

The core will serve as a center for receiving, qualifying, processing, and distributing annotated biospecimens to the Clinical Proteomic Tumor Analysis Consortium (CPTAC).

CPTAC initiative has done protein biomarker discovery and verification studies in tumor tissue samples previously characterized at the genomic and transcriptomic level by the NCI's Cancer Genome Atlas (TCGA) team. In the first phase of the project, participating researchers undertook analysis of three tumor types — breast, colorectal, and ovarian.

In the next phase the project aims to extend their analysis to additional cancer types. According to the agency, this work will require the acquisition of high-quality, clinically annotated, primary, and untreated tumor specimens from patients with specific cancer types.

Tissue Source Sites will prospectively collect samples consisting of primary human tumors, blood, and non-malignant tissue according to protocols optimized for proteomics, which will then be passed on to the Biospecimen Core Resource.

Advertisement